Long Non-coding RNA DLEU2L Targets miR-210-3p to Suppress Gemcitabine Resistance in Pancreatic Cancer Cells via BRCA2 Regulation
Cited by 29
Related Papers
Exosomes derived from cancer stem cells of gemcitabine-resistant pancreatic cancer cells enhance drug resistance by delivering miR-210
|Cellular Oncology|2019|195
MicroRNA‐375‐3p enhances chemosensitivity to 5‐fluorouracil by targeting thymidylate synthase in colorectal cancer
|Cancer Science|2020|105
The interaction of LOXL2 with GATA6 induces VEGFA expression and angiogenesis in cholangiocarcinoma
|International Journal of Oncology|2019|45
miR-506 functions as a tumor suppressor in glioma by targeting STAT3
|Oncology Reports|2015|39
<p>MACC1 promotes angiogenesis in cholangiocarcinoma by upregulating VEGFA</p>
|OncoTargets and Therapy|2019|16